Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2015 Aug 27:13:97.
doi: 10.1186/s12958-015-0096-y.

Intracytoplasmic morphologically selected sperm injection versus conventional intracytoplasmic sperm injection: a randomized controlled trial

Affiliations
Randomized Controlled Trial

Intracytoplasmic morphologically selected sperm injection versus conventional intracytoplasmic sperm injection: a randomized controlled trial

Giovanni Battista La Sala et al. Reprod Biol Endocrinol. .

Retraction in

Abstract

Background: Intracytoplasmic morphologically selected sperm injection (IMSI) is still proposed and employed in the clinical practice to improve the reproductive outcome in infertile couples scheduled for conventional intracytoplasmic sperm injection (cICSI). The aim of the current randomized controlled trial (RCT) was to test the hypothesis that IMSI gives a better live birth delivery rate than cICSI.

Methods: Infertile couples scheduled for their first cICSI cycle for male factor were allocated using a simple randomization procedure. All available biological and clinical data were recorded and analyzed in a triple-blind fashion.

Results: Our final analysis involved the first 121 patients (48 and 73 subjects for IMSI and cICSI arm, respectively) because the trial was stopped prematurely on the advice of the data safety and monitoring Committee because of concerns about IMSI efficacy at the first interim analysis. No significant difference between arms was detected in rates of clinical pregnancy per embryo transferred [11/34 (32.3%) vs. 15/64 (23.4%); odds ratio (OR) 1.56, 95% (confidence interval) CI 0.62-3.93, P = 0.343] and of live birth delivery [9/48 (18.8%) vs. 11/73 (15.1%); OR 1.30, 95%CI 0.49-3.42, P = 0.594).

Conclusion: Current data did not support the routine use of IMSI in the clinical practice for improving cICSI results in unselected infertile couples with male factor.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Trial flow-chart according to the CONSORT guidelines [12, 13]
Fig. 2
Fig. 2
Data synthesis for the main reproductive outcome measures of the published RCTs on unselected infertile populations

References

    1. Practice Committees of the American Society for Reproductive Medicine and Society for Assisted Reproductive Technology Intracytoplasmic sperm injection (ICSI) for non-male factor infertility: a committee opinion. Fertil Steril. 2012;98:1395–9. doi: 10.1016/j.fertnstert.2012.08.026. - DOI - PubMed
    1. Mansour R. Intracytoplasmic sperm injection: a state of the art technique. Hum Reprod Update. 1998;4:43–56. doi: 10.1093/humupd/4.1.43. - DOI - PubMed
    1. Bartoov B, Berkovitz A, Eltes F, Kogosowski A, Menezo Y, Barak Y. Real-time fine morphology of motile human sperm cells is associated with IVF-ICSI outcome. J Androl. 2002;23:1–8. - PubMed
    1. Boitrelle F, Guthauser B, Alter L, Bailly M, Bergere M, Wainer R, et al. High-magnification selection of spermatozoa prior to oocyte injection: confirmed and potential indications. Reprod Biomed Online. 2014;28:6–13. doi: 10.1016/j.rbmo.2013.09.019. - DOI - PubMed
    1. Nadalini M, Tarozzi N, Distratis V, Scaravelli G, Borini A. Impact of intracytoplasmic morphologically selected sperm injection on assisted reproduction outcome: a review. Reprod Biomed. 2009;19:45–55. doi: 10.1016/S1472-6483(10)60283-0. - DOI - PubMed

Publication types

LinkOut - more resources